October 5, 2021 CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19
October 3, 2021 View Now: IBD Biomarker Regulatory Science Webinar Wednesday, March 10, 10 a.m. ET The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD
September 30, 2021 C-Path and Pulse Infoframe Establish Patient-Centered Data Harmonization Partnership to Accelerate Collaborative Research in Rare Disease LONDON, Canada and TUCSON, Ariz., U.S., September 30, 2021, 2021 — Critical Path Institute (C-Path) and Pulse Infoframe announce
September 29, 2021 Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
September 16, 2021 C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D.,
September 15, 2021 Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz.
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat
September 14, 2021 Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
